Fezolinetant is an orally-active neurokinin-3 (NK3) receptor antagonist that is in a race to market with another candidate in the class from UK-based women’s health specialist KaNDy Therapeutics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback